Back to Results
First PageMeta Content
Health / Investigational New Drug / Drug development / Regulatory requirement / Center for Biologics Evaluation and Research / Prescription Drug User Fee Act / New Drug Application / ClinicalTrials.gov / Structured Product Labeling / Food and Drug Administration / Medicine / Pharmaceutical sciences


Federal Register / Vol. 80, No[removed]Tuesday, March 31, [removed]Notices The Food and Drug Administration (FDA) is announcing a request for additional comments on the chemistry, manufacturing, and control (CMC) information
Add to Reading List

Document Date: 2015-03-31 08:02:18


Open Document

File Size: 182,64 KB

Share Result on Facebook

City

Washington / DC / Rockville / /

Company

Vertex Pharmaceuticals / /

Country

United States / /

/

Facility

Hillandale Building / /

/

IndustryTerm

live biotherapeutic products / treatment of cystic fibrosis / manufacturing / investigational new drug applications / food / /

MedicalCondition

cystic fibrosis transmembrane conductance regulator / cystic fibrosis / /

MedicalTreatment

dietary supplement / dietary supplements / /

Organization

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration / Pulmonary-Allergy Drugs Advisory Committee / office of Communication / Outreach and Development / Food and Drug Administration / Division of Drug Information / Division of Dockets Management / NOTICES / Availability AGENCY / office of Management and Budget / FDA’s Center for Drug Evaluation and Research / Center for Biologics Evaluation and Research / Meeting AGENCY / Drug Administration / PulmonaryAllergy Drugs Advisory Committee / /

Person

Alicia Barbieri Stuart / Silver Spring / Leslie Kux / /

/

Position

Governor / Associate Commissioner for Policy / /

Product

Expediting Drug / /

ProvinceOrState

Maryland / Indiana / /

Technology

http / drug development / /

URL

http /

SocialTag